Invention Grant
- Patent Title: Ebola virus antibodies and binding agents derived therefrom
-
Application No.: US17196418Application Date: 2021-03-09
-
Publication No.: US11713349B2Publication Date: 2023-08-01
- Inventor: Rafi Ahmed , Carl Davis , Erica Ollmann Saphire
- Applicant: Emory University , The Scripps Research Institute
- Applicant Address: US GA Atlanta
- Assignee: Emory University,The Scripps Research Institute
- Current Assignee: Emory University,The Scripps Research Institute
- Current Assignee Address: US GA Atlanta; US CA La Jolla
- Agency: Emory Patent Group
- Main IPC: C07K16/10
- IPC: C07K16/10 ; C12Q1/70 ; A61P31/14
Abstract:
This disclosure relates to antibodies and antigen binding fragments that specifically bind Ebola virus particles. In certain embodiments, the antibodies and fragments are capable of treating or preventing an Ebola viral infection. In certain embodiments, the antibodies and antigen binding fragments are also contemplated for diagnostic methods and compositions related thereto.
Public/Granted literature
- US20210221872A1 Ebola Virus Antibodies and Binding Agents Derived Therefrom Public/Granted day:2021-07-22
Information query
